Deficiency of myeloperoxidase and abnormal chromosome 1 occurs in variant (HL60) promyelocytes

Establishment of a stable HL60 subline having the potential for monocytic differentiation using granulocyte-macrophage colony-stimulating factor: possible use for the study of monocytic differentiation and oxidative stress

A stable HL60 subline having the potential for monocytic differentiation was established by use of GM-CSF. HL60, a human promyelocytic cell line, has frequently been employed for research in the fields of monocytic differentiation and atherosclerosis because of its potential to differentiate into either granulocytes or monocytes. However, HL60 are frequently seen to change their phenotype during long-term culture. To date, many sublines or variants of HL60 cells have been established. However, most of them display diminished or complete loss of activities that characterize parental cells. The present study was conducted to establish a stable HL60 subline with the potential for monocytic differentiation. Firstly, a single HL60 cell was isolated by limiting dilution, and was successfully proliferated by incubation with GM-CSF. Secondly, from this population, cells were selected that had the ability to generate superoxide after VD-induced monocytic differentiation. Cells obtained in this manner (designated HL60/DU-1) exhibited expression of CD14 and CD11b and suppression of CD3 expression after monocytic differentiation. NBT positivity showed a consistent level of over 971% after a 6-day challenge with VD throughout the experimental period of 12 months. HL60/DU-1 cells, which were cryopreserved in liquid nitrogen for 6 months, thawed and re-cultured, exhibited over 97% NBT positivity. Carvedilol and probucol, which exhibit antioxidative activity, inhibited superoxide release from the differentiated HL60/DU-1 cells. HL60/DU-1 cell line is a promising model for the study of monocytic differentiation and the effects of oxygen radicals.

Different molecular forms of a glycoprotein antigen found on azurophilic granule membranes of cultured human HL60 promyelocytes and on the plasma membrane of a myeloblastoid variant line

In previous immunohistological studies an antigen designated D46 was identified on the surface of an agranular, myeloblastoid cell line (HL60-D). It was not detected on the surface of either parental HL60 cells or variants with aberrant primary granules (HL60-A7). In these promyelocytes it was found to be intracytoplasmic, in a granular pattern. In the work presented here, this antigen and other granule-related glycoproteins were studied by radiolabeling, subcellular fractionation and gel electrophoresis. The major findings include the following: the anti-D46 antibody precipitated one major and one minor glycosylated component, each of which migrated with a different electrophoretic mobility, depending on whether it was derived from cells with or without granules. Incorporation of radioactive amino acids, but not monosaccharides, revealed an additional component of lower mobility. The D46 antigen(s) was recovered in the detergent-rich phase of a Triton X-114 extract of granules, suggesting that it is an integral membrane protein. As assessed by the relative activities of marker enzymes, the granules of both the HL60 and HL60-A7 cell lines exhibited a heterogeneous pattern of sedimentation in density gradients. The electrophoretic patterns of the major [2-3H]mannose-labeled glycoproteins of the granule-enriched fractions were similar, except for one diffuse band of 110-170 kD which was not detected in HL60-A7. These studies provide direct evidence for heterogeneity of enzymatic and membrane constituents of primary myeloid granules, and give the first indication that there may be glycoprotein changes associated with certain ultra-structural defects that occur in abnormal promyelocytes. They suggest also, in the example of the D46 antigen; that some glycoproteins may exist in different forms when localized to either the granules or the plasma membrane.

Differences in the plasma membrane glycoproteins of cultured myeloblastoid and promyelocytic human leukemia (HL60) cells

Since the mechanisms that control synthesis of surface and internal granule membranes are closely-related within the Golgi apparatus, we have compared the plasma membrane proteins and glycolipids of cells of the human promyelocytic line HL-60 with those of its agranular myeloblastoid variant (HL60-D), and of other human myeloid lines (KG-1a, KG-1 and ML-2). Proteolytic degradation by granule enzymes altered the protein profiles unless multiple inhibitors were included in the cell suspension before lysis and during subsequent handling of the extracts. Polyacrylamide gel electrophoretic profiles of the proteins accessible to lactoperoxidase-catalyzed 125I-labeling or to periodate [3H]-borohydride labeling, as well as those of the glycoproteins bound to and eluted from immobilized concanavalin A, showed distinct patterns. The apparent molecular weights of the two major sialylated glycoproteins were larger in cell lines with a greater content of azurophilic granules. Also, the blastic line incorporated less fucose into glycolipid and contained less complex gangliosides and neutral glycolipids than did the parent. These data demonstrate that, within the limits of this culture model, cells capable of cytoplasmic granule production express a different constellation of surface components.